SEC 13F Intelligence

Checkpoint Capital L.P. / CDTX

Checkpoint Capital L.P.’s Cidara Therapeutics Inc Position

Does Checkpoint Capital L.P. own Cidara Therapeutics Inc (CDTX)? Not currently — the last reported position was 104.4K shares worth $2M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q1 2025
Shares
104.4K
% of Portfolio
+1.23%
Quarters Held
4
position exited

Position History CDTX

Reported value by quarter
Q2 ’24: $2MQ2 ’24Q3 ’24: $2MQ3 ’24Q4 ’24: $5MQ4 ’24Q1 ’25: $2MQ1 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2025104.4K$2M+1.23%
Q4 2024196.9K$5M+2.60%
Q3 2024182.4K$2M+0.97%
Q2 2024145.4K$2M+1.05%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Checkpoint Capital L.P.’s full portfolio or all institutional holders of CDTX.